US stock · Healthcare sector · Medical Care Facilities

DaVita Inc.

DVA

NYSE

95.42

USD

+2.01

(+2.15%)

Pre Market

11.27P/E

9Forward P/E

0.43P/E to S&P500

9.027BMarket CAP

- -Div Yield

Summary Financials Transcripts Monitoring Classic View

Upcoming Earnings

1 Aug-5 Aug

Shares Short

4/29/22

2.83M

Short % of Float

4.87%

Short % of Shares Outs.

2.99%

% Held by Insiders

2.92%

% Held by Institutions

88.69%

Beta

1.13

PEG Ratio

0.94

52w. high/low

136.48/91.73

Avg. Daily Volume

0.69M

Return %

Stock

S&P 500

1 year

(21.04)

(6.01)

3 years

99.08

39.24

5 years

45.57

63.25

Scale: |

High

Low

33.72

25.38

30.11

20.48

30.98

20.61

37.30

28.29

44.88

29.57

58.25

38.30

65.67

52.75

78.52

62.52

85.17

67.34

78.77

54.50

72.93

52.51

80.71

48.25

75.30

43.40

117.65

62.20

136.48

94.38

124.81

91.73

Currency: USD

2006

2007

2008

2009

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

TTM

Revenue per share

23.57

24.86

26.91

29.48

31.76

36.88

42.63

56.04

60.27

65.05

73.13

57.66

66.78

74.35

96.42

110.41

113.77

Earnings per share

1.40

1.80

1.78

2.04

2.00

2.52

2.79

3.02

3.41

1.27

4.36

3.52

0.93

5.29

6.46

9.30

8.78

FCF per share

1.21

1.22

1.13

1.89

2.79

4.12

2.87

5.51

3.85

4.01

5.63

5.31

4.59

8.52

10.89

12.25

14.49

Dividends per share

- -

0.33

0.41

- -

CAPEX per share

1.30

1.51

1.33

1.35

2.11

2.86

2.94

3.03

3.34

4.11

4.80

5.78

5.00

5.63

6.10

6.07

Book Value per sh.

6.02

8.18

9.28

10.30

9.75

11.31

19.60

21.11

24.35

22.99

23.05

24.86

21.68

13.93

11.55

7.18

9.86

Comm.Shares outs.

207

212

210

207

203

189

192

210

212

202

189

171

153

120

105

102

Avg. annual P/E ratio

19.6

15.7

14.6

12.4

16.2

15.4

17.0

19.5

20.9

60.6

15.8

18.1

73.6

10.8

13.3

12.4

11.3

P/E to S&P500

1.1

0.9

0.7

0.2

0.8

0.9

1.1

1.2

3.0

0.7

0.8

2.9

0.4

Avg. annual div. yield

- -

1.3%

- -

Revenue (m)

4,881

5,264

5,660

6,109

6,447

6,982

8,186

11,764

12,795

13,782

14,745

10,877

11,405

11,388

11,551

11,619

11,616

Operating margin

15.2%

16.4%

14.5%

15.4%

15.5%

16.2%

15.8%

13.2%

14.2%

8.5%

12.8%

16.7%

13.4%

14.4%

14.7%

15.5%

14.6%

Depreciation (m)

173

193

217

229

234

267

344

528

591

638

720

777

591

615

630

681

688

Net profit (m)

290

382

374

423

406

478

536

633

723

270

880

664

159

811

774

978

903

Income tax rate

39.2%

38.6%

36.7%

35.0%

35.4%

35.9%

33.9%

34.1%

40.9%

30.6%

23.1%

24.6%

23.4%

23.8%

20.2%

20.1%

Net profit margin

5.9%

7.3%

6.6%

6.9%

6.3%

6.8%

6.5%

5.4%

5.7%

2.0%

6.0%

6.1%

1.4%

7.1%

6.7%

8.4%

7.8%

Working capital (m)

597

890

965

1,256

1,699

1,128

861

1,010

1,788

2,104

1,284

5,703

3,533

1,318

673

769

708

Long-term debt (m)

3,730

3,684

3,622

3,563

4,234

4,418

8,327

8,141

8,383

9,001

8,947

9,158

8,173

7,978

10,656

11,402

11,310

Equity (m)

1,246

1,732

1,952

2,135

1,978

2,141

3,763

4,432

5,171

4,871

4,648

4,690

3,703

2,133

1,384

756

844

ROIC

5.5%

6.7%

6.3%

8.7%

7.7%

8.8%

5.5%

6.6%

3.6%

7.7%

6.9%

4.9%

8.0%

7.4%

8.6%

9.0%

Return on capital

7.5%

9.2%

8.6%

11.8%

10.5%

11.8%

7.5%

8.5%

8.9%

5.3%

9.4%

7.6%

4.8%

9.0%

8.3%

9.3%

9.5%

Return on equity

23.3%

22.0%

19.2%

19.8%

20.5%

22.3%

14.2%

14.3%

14.0%

5.5%

18.9%

14.1%

4.3%

38.0%

55.9%

129.5%

107.0%

Plowback ratio

100.0%

84.0%

79.4%

100.0%

Div.&Repurch./FCF

(16.2)%

(21.9)%

80.9%

52.5%

124.0%

41.5%

- -

64.8%

96.8%

80.1%

148.1%

182.6%

111.9%

124.0%

102.5%

Capital Structure

5 May · 2022 | Q1

All numbers in millions

Total liabilities

$ 14,678

Total assets

$ 17,087

Long-term debt

$ 11,310

Cash and equiv.

$ 328

Goodwill

$ 7,073

Retained earnings

$ 516

Common stock

Enterprise Value

$ 20,009

Working Capital

Currency: USD, in millions

2019

2020

2021

Cash & Investments

1,114

345

484

Receivables

2,305

2,439

2,411

Inventory

112

107

Other

173

(524)

(475)

Current assets

3,690

3,149

3,168

Acc. Payable

404

434

402

Debt due

475

538

573

Other

1,494

1,504

1,423

Current liabilities

2,372

2,476

2,399

Annual growth rates

(avg. rate of change)

1 year

5 years

10 years

Revenue

0.59%

1.68%

5.30%

Cash flow

(1.16)%

10.87%

16.66%

Earnings

26.47%

88.67%

58.44%

Dividends

- -

Book value

(45.39)%

(35.99)%

(13.22)%

Insider Trading

Type

Date

Yale Phyllis R

Award

475

05/15/22

Waters Kathleen Alyce

InKind

3,703

05/15/22

Waters Kathleen Alyce

InKind

6,500

05/15/22

Waters Kathleen Alyce

InKind

1,676

05/15/22

Waters Kathleen Alyce

InKind

5,486

05/15/22

Quarterly Revenue

Currency: USD, in millions

Year

Total

2020

2,841

2,880

2,924

2,905

11,551

2021

2,820

2,917

2,938

2,944

11,619

2022

2,818

- -

Earnings per share

Currency: USD

Year

Total

2020

2.00

1.68

1.32

1.45

6.46

2021

2.26

2.79

2.47

1.78

9.30

2022

1.68

- -

Quarterly dividends paid

Currency: USD

Year

Total

2020

- -

2021

- -

2022

- -

Company Description

Sector:

Healthcare

Industry:

Medical Care Facilities

CEO:

Mr. Javier Rodriguez

Full-time employees:

69,000

City:

Denver

Address:

2000 16th St

IPO:

Oct 31, 1995

CIK:

0000927066

Website:

davita.com

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.

Powered by AI

DaVita Inc.

95.42